Abstract
Eighty eight patients with hyperlipidaemia (81 white patients from South Africa and seven patients of mixed race from the West Cape area) were studied. Forty eight had adult familial hypercholesterolaemia, 16 had juvenile familial hypercholesterolaemia, and 24 had mixed hyperlipidaemia (increased cholesterol and triglycerides). They were interviewed and examined and their musculoskeletal manifestations compared with 88 controls with normal lipid profiles, and matched for age, sex, and race for each group of patients. The foliowing manifestations were significantly increased in the patients: (a) tendon xanthomas particularly of the tendo Achiflis in patients with adult familial hypercholesterolaemia and mixed hyperlipidaemia; (b) A number of studies suggest that there is an association between hyperlipidaemia and tendon xanthomas, tendo Achillis tendinitis, transient tendo Achillis pain, migratory polyarthritis, and oligoarthritis. '-' The reported prevalence of these manifestations varies widely from study to study because of differences in classification of the hyperlipidaemias, patient selection, and study design. Interpretation of the findings, none of which included control patients, is difficult especially where prevalence figures are low. Migratory polyarthritis appears to be particularly associated with homozygous familial hypercholesterolaemia.' There are, however, other uncontrolled studies which show no specific associations between hyperlipidaemia and rheumatic disorders.' '1 In the one controlled study the only difference between patients with hypercholesterolaemia and controls was that pain, particularly of the ankles and feet, was significantly more severe in the patients. " There was no difference in the duration of morning stiffness, analgesic use, or effect on lifestyle. This study cannot be compared with others, however, as specific entities such as xanthomas and migratory polyarthritis were not reported.
We documented the musculoskeletal system manifestations of 88 patients with hyperlipidaemia and compared them with 88 age and sex matched controls. The patients were subdivided into groups with different lipid profiles. The onset of the manifestations in relation to the diagnosis of hyperlipidaemia and the effect of lipid lowering treatment on the manifestations were also investigated.
Patients and methods Eighty eight consecutive patients with hyperlipidaemia attending the lipid clinic at Tygerberg Hospital were studied. They were interviewed with a detailed questionnaire and examined, and the following information was recorded: age, sex, family history of hyperlipidaemia or ischaemic heart disease, musculoskeletal system manifestations past or present, cholesterol and triglyceride levels in patients with and without musculoskeletal system manifestations, the effect of lipid lowering treatment on musculoskeletal system manifestations, and whether the onset of musculoskeletal system disorders antedated or followed the diagnosis of hyperlipidaemia. Particular attention was paid to a history of migratory polyarthritis, oligoarthritis, Fifty seven (65%) of the 88 patients and 10 (1 1%) controls had one or more of the musculoskeletal system manifestations claimed to be associated with hyperlipidaemia (p<0001), namely tendon xanthomas, tendo Achillis tendinitis, transient Achilles tendon pain, oligoarthritis and migratory polyarthritis. One or more of these manifestations occurred in significantly more patients with adult familial hypercholesterolaemia and mixed hyperlipidaemia than controls (figure). The difference in patients with juvenile familial hypercholesterolaemia and controls was not significant. Table 2 gives the pretreatment cholesterol and triglyceride levels in patients with and without musculoskeletal system manifestations and the significance of these. The significance of triglyceride levels in the adult familial hypercholesterolaemia and juvenile familial hypercholesterolaemia groups was not tested because normal levels were used to establish the groups.
ONSET OF MUSCULOSKELETAL SYSTEM MANIFESTATIONS
Thirty nine of the 57 (68%) patients with musculoskeletal system manifestations associated with hyperlipidaemia were able to recall whether their symptoms antedated or followed the diagnosis of hyperlipidaemia. In 24 (62%) of these patients the musculoskeletal system manifestations preceded the diagnosis and in 15 (38%) they had developed after the diagnosis had been made. The difference was not significant (p=069). We showed a significant association between pretreatment cholesterol levels in the patients with adult familial hypercholesterolaemia and in the three groups combined, further suggesting a link between cholesterol levels and the risk of developing musculoskeletal system manifestations. Although not significant, there is some indication that increased triglyceride levels may also predispose to musculoskeletal system manifestations.
Our study confirms the findings in other studies that musculoskeletal system manifestations may antedate the diagnosis of hyperlipidaemia.2 ' Recognition of these manifestations, particularly in children and in subjects with a strong family history of ischaemic heart disease, may contribute to early diagnosis and appropriate treatment of the underlying metabolic disorder.
There are difficulties with the classification of the hyperlipidaemias. Our data suggest that although tendon xanthomas are highly suggestive of familial hyperlipidaemia (Frederickson type IIA), they are often absent in young patients with familial hyperlipidaemia. The diagnosis of familial hyperlipidaemia should therefore not be dependent on xanthomas in young people. In addition, a subject with familial hyperlipidaemia may also have hypertriglyceridaemia due to mixed hyperlipidaemia or to diabetes mellitus, excessive alcohol consumption, obesity, or the use of drugs such as I6 blockers.
The pathogenesis of the musculoskeletal system manifestations in hyperlipidaemia is not fully understood. There is evidence suggesting that the arthropathy is a true inflammatory synovitis,' is periarticular,6 or that it is induced by crystals. Cholesterol clefts have been shown in xanthomas'5 and positively birefringent suspected lipid crystals identified in fluid aspirated from a retrocalcaneal bursa and a tendo Achillis nodule in a patient with hypercholesterolaemia. 16 It has also been suggested that tendinitis may be precipitated by unaccustomed exertion.3 Most of our patients did not associate episodes of tendo Achillis tendinitis with exertion. The significant association between tendo Achillis tendinitis and xanthomas in our study suggests that the xanthomas themselves may play a part in the pathogenesis, possibly by producing an inflammatory reaction on a mechanical basis.
In our study the musculoskeletal system manifestations of some patients improved after lipid lowering treatment. To establish whether control of the hyperlipidaemia will alleviate the musculoskeletal system manifestations requires long term prospective studies relating serial lipid profiles to musculoskeletal system manifestations. We thank Professor H F H Weich, head of the department of cardiology for permission to study patients attending the lipid clinic and Professor J J F Taliaard and his staff, department of chemical pathology for performing the lipid profiles.
